Finnland - finnska - Fimea (Suomen lääkevirasto)

orion corporation - modafinil - tabletti - 100 mg - modafiniili

Finnland - finnska - Fimea (Suomen lääkevirasto)

orion corporation - modafinil - tabletti - 200 mg - modafiniili

Finnland - finnska - Fimea (Suomen lääkevirasto)

krka, d.d., novo mesto - linezolid - tabletti, kalvopäällysteinen - 600 mg - linetsolidi

Finnland - finnska - Fimea (Suomen lääkevirasto)

orion corporation - linezolidum - tabletti, kalvopäällysteinen - 600 mg - linetsolidi

Finnland - finnska - Fimea (Suomen lääkevirasto)

uab norameda - linezolid - infuusioneste, liuos - 2 mg/ml - linetsolidi

Finnland - finnska - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - linezolid - infuusioneste, liuos - 2 mg/ml - linetsolidi

Finnland - finnska - Fimea (Suomen lääkevirasto)

jurox (ireland) limited - alfaxalone - injektioneste, liuos - 10 mg/ml - alfaksaloni

Evrópusambandið - finnska - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiset aineet - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Evrópusambandið - finnska - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiset aineet - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Finnland - finnska - Fimea (Suomen lääkevirasto)

macure pharma aps - verapamil hydrochloride - injektio-/infuusioneste, liuos - 2.5 mg/ml - verapamiili